Designing Higher-Quality Medicines with Next-Generation Computational Drug Discovery
Pending Al seamlessly integrates scalable quantum mechanics and artificial intelligence to create a platform capable of unlocking new drug discovery possibilities.
Combining the Past and Future to Transform Drug Discovery
By fusing the vast chemical and biological knowledge of traditional pharmaceutical drug discovery with advanced technologies such as scalable artificial intelligence and quantum mechanics, Pending AI is chartering the future of therapeutic design.
Quantum-Based Structural Biology
Pending AI starts by leveraging quantum mechanical calculations to model disease protein target structural data at a level of precision unachievable with classical methods. This unlocks new insights into protein conformations and reveals hidden druggable pockets. By refining protein structures with quantum accuracy, we enable first-in-class and best-in-class pharmaceutical development.
Artificial Intelligence-Guided Drug Libraries and Profile Optimization
Our generative artificial intelligence engine explores trillion-scale virtual chemical space, with benchmarking ensuring adherence to gold-standard pharmacological metrics. Our drug library is coupled with an ultra-high-throughput retrosynthesis engine to determine synthetic accessibility, quantum chemical calculations to model precise three-dimensional configuration and their interaction with target binding sites, and reinforcement learning for multi-parameter drug optimization. This radically enhances hit identification and candidate optimization at preclinical stages.
Expanding the Horizons of what Traditional Drug Discovery can Achieve
Using next-generation quantum physics and artificial intelligence capabilities, Pending AI is re-defining what is possible in computational drug discovery.
Treating the Untreatable
Unlocking historically ‘difficult-to-drug’ targets with protein structure refinement.
Precision From the Start
Quantum mechanics provides the highest-accuracy in silico description of proteins and drugs possible.
Massive Scale, Meaningful Possibilities
Trillion-scale compound libraries unlock pharmaceutical space yet to be explored.
From Science Fiction to Patient Reality
Drug profiles optimized before synthesis — not after failure.
